CORRIGENDUM


In Vitro Inhibition of Staphylococcus aureus subsp. aureus (ATCC® 6538™) by Artemether-Lumefantrine Tablets: A Comparative Study of Three Dosage Strengths



Opoku Solomon1, *, Nyanor Isaac2
1 Department of Quality Control, Entrance Pharmaceuticals and Research Centre, No. 16 Okpoi Gonno, Spintex Road, Post Office Box CT 10805, Accra, Ghana
2 Sickle Pan Africa Research Consortium, Kumasi Centre for Sickle Cell Disease, Komfo Anokye Teaching Hospital, Kumasi, Ghana


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 420
Abstract HTML Views: 421
PDF Downloads: 124
ePub Downloads: 169
Total Views/Downloads: 1134
Unique Statistics:

Full-Text HTML Views: 298
Abstract HTML Views: 219
PDF Downloads: 92
ePub Downloads: 116
Total Views/Downloads: 725



© 2019 Solomon and Isaac.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.





In Vitro Inhibition of Staphylococcus aureus subsp. aureus (ATCC® 6538™) by Artemether-Lumefantrine Tablets: A Comparative Study of Three Dosage Strengths

The Open Microbiology Journal, 2018, 12: 397-403.

1- The correct word in running title in header is mentioned below:

aureus subsp.

The original word in running title in header was:

Aureus subsp.

2- The following unnecessary text was removed from the page number 400 & 401.

  • This table is modified from Clinical and Laboratory Standards Institute. (2016). Performance standards for antimicrobial susceptibility testing; 26th ed. CLSI M100S. Clinical and Laboratory Standards Institute, Wayne, PA.
  • These are footnote texts for Tables 1 and 2. Should be cut and pasted at the appropriate places.